Antisense oligonucleotide therapy : Nature Communications subject feeds
https://www.nature.com/subjects/antisense-oligonucleotide-therapy/ncomms.atom
2024-03-28T14:30:03+00:00
Publisher Correction: Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry
https://www.nature.com/articles/s41467-023-44590-4
2024-01-04T00:00:00+00:00
2024-01-04T00:00:00+00:00
Chisato Terada et al.
Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry
https://www.nature.com/articles/s41467-023-43714-0
2023-12-02T00:00:00+00:00
2023-12-02T00:00:00+00:00
Chisato Terada et al.
Secondary structures that regulate mRNA translation provide insights for ASO-mediated modulation of cardiac hypertrophy
https://www.nature.com/articles/s41467-023-41799-1
2023-10-03T00:00:00+00:00
2023-10-03T00:00:00+00:00
Omar M. Hedaya et al.
Fluorinated polyamidoamine dendrimer-mediated miR-23b delivery for the treatment of experimental rheumatoid arthritis in rats
https://www.nature.com/articles/s41467-023-36625-7
2023-02-20T00:00:00+00:00
2023-02-20T00:00:00+00:00
Haobo Han et al.
XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection
https://www.nature.com/articles/s41467-022-34339-w
2022-11-16T00:00:00+00:00
2022-11-16T00:00:00+00:00
Pehuén Pereyra Gerber et al.
An LNA-amide modification that enhances the cell uptake and activity of phosphorothioate exon-skipping oligonucleotides
https://www.nature.com/articles/s41467-022-31636-2
2022-07-12T00:00:00+00:00
2022-07-12T00:00:00+00:00
Ysobel R. Baker et al.
Gene-specific nonsense-mediated mRNA decay targeting for cystic fibrosis therapy
https://www.nature.com/articles/s41467-022-30668-y
2022-05-27T00:00:00+00:00
2022-05-27T00:00:00+00:00
Young Jin Kim et al.
DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo
https://www.nature.com/articles/s41467-021-26902-8
2021-12-22T00:00:00+00:00
2021-12-22T00:00:00+00:00
Masaki Ohyagi et al.
Short antisense oligonucleotides alleviate the pleiotropic toxicity of RNA harboring expanded CGG repeats
https://www.nature.com/articles/s41467-021-21021-w
2021-02-24T00:00:00+00:00
2021-02-24T00:00:00+00:00
Magdalena Derbis et al.
Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models
https://www.nature.com/articles/s41467-021-21112-8
2021-02-08T00:00:00+00:00
2021-02-08T00:00:00+00:00
Yuanjing Liu et al.
Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression
https://www.nature.com/articles/s41467-020-17093-9
2020-07-09T00:00:00+00:00
2020-07-09T00:00:00+00:00
Kian Huat Lim et al.
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5
https://www.nature.com/articles/s41467-020-16605-x
2020-06-02T00:00:00+00:00
2020-06-02T00:00:00+00:00
Tomohiko Yamamura et al.
Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson–Gilford Progeria Syndrome
https://www.nature.com/articles/s41467-019-13018-3
2019-11-18T00:00:00+00:00
2019-11-18T00:00:00+00:00
Julio Aguado et al.
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis
https://www.nature.com/articles/s41467-018-03627-9
2018-04-12T00:00:00+00:00
2018-04-12T00:00:00+00:00
Margaux Sevin et al.
Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice
https://www.nature.com/articles/ncomms15661
2017-06-07T00:00:00+00:00
2017-06-07T00:00:00+00:00
Hichem Tasfaout et al.
Light-inducible antimiR-92a as a therapeutic strategy to promote skin repair in healing-impaired diabetic mice
https://www.nature.com/articles/ncomms15162
2017-05-02T00:00:00+00:00
2017-05-02T00:00:00+00:00
Tina Lucas et al.